BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11498790)

  • 1. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication.
    Satyamoorthy K; Muyrers J; Meier F; Patel D; Herlyn M
    Oncogene; 2001 Aug; 20(34):4676-84. PubMed ID: 11498790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion.
    Shih IM; Speicher D; Hsu MY; Levine E; Herlyn M
    Cancer Res; 1997 Sep; 57(17):3835-40. PubMed ID: 9288796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
    Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
    Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
    Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
    Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
    Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
    Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CD146 (Mel-CAM) in biology and pathology.
    Shih IM
    J Pathol; 1999 Sep; 189(1):4-11. PubMed ID: 10451481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of melanoma metastasis.
    Bar-Eli M
    J Cell Physiol; 1997 Nov; 173(2):275-8. PubMed ID: 9365536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.
    Hsu MY; Meier FE; Nesbit M; Hsu JY; Van Belle P; Elder DE; Herlyn M
    Am J Pathol; 2000 May; 156(5):1515-25. PubMed ID: 10793063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes.
    Shih IM; Elder DE; Hsu MY; Herlyn M
    Am J Pathol; 1994 Oct; 145(4):837-45. PubMed ID: 7943174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
    Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
    Shih IM; Kurman RJ
    Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelation of motility, cytoskeletal organization and gap junctional communication with invasiveness of melanocytic cells in vitro.
    Helige C; Zellnig G; Hofmann-Wellenhof R; Fink-Puches R; Smolle J; Tritthart HA
    Invasion Metastasis; 1997; 17(1):26-41. PubMed ID: 9425322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.
    Pickl WF; Majdic O; Fischer GF; Petzelbauer P; Faé I; Waclavicek M; Stöckl J; Scheinecker C; Vidicki T; Aschauer H; Johnson JP; Knapp W
    J Immunol; 1997 Mar; 158(5):2107-15. PubMed ID: 9036955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling.
    Li G; Fukunaga M; Herlyn M
    Exp Cell Res; 2004 Jul; 297(1):142-51. PubMed ID: 15194432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma.
    Shih LM; Hsu MY; Palazzo JP; Herlyn M
    Am J Pathol; 1997 Sep; 151(3):745-51. PubMed ID: 9284823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic expression of carcinoembryonic antigen by a melanoma cell leads to changes in the transcription of two additional cell adhesion molecules.
    Grimm T; Johnson JP
    Cancer Res; 1995 Aug; 55(15):3254-7. PubMed ID: 7614458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue.
    Shih IM; Nesbit M; Herlyn M; Kurman RJ
    Mod Pathol; 1998 Nov; 11(11):1098-106. PubMed ID: 9831208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion receptors in human melanoma progression.
    Nesbit M; Herlyn M
    Invasion Metastasis; 1994-1995; 14(1-6):131-46. PubMed ID: 7657508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
    McGary EC; Heimberger A; Mills L; Weber K; Thomas GW; Shtivelband M; Lev DC; Bar-Eli M
    Clin Cancer Res; 2003 Dec; 9(17):6560-6. PubMed ID: 14695161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.